Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
12.73
-0.71 (-5.28%)
At close: Apr 7, 2026, 4:00 PM EDT
12.78
+0.04 (0.35%)
After-hours: Apr 7, 2026, 4:17 PM EDT
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $475.29 million as of April 7, 2026. Its market cap has increased by 156.94% in one year.
Market Cap
475.29M
Enterprise Value
220.64M
1-Year Change
156.94%
Ranking
Category
Stock Price
$12.73
Market Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has increased from $402.09M to $475.29M, an increase of 18.20%. That is a compound annual growth rate of 8.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 501.80M | 20.18% |
| Dec 31, 2025 | 417.53M | 10.56% |
| Dec 31, 2024 | 377.64M | -6.08% |
| Apr 5, 2024 | 402.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fulcrum Therapeutics | 521.48M |
| Eikon Therapeutics | 511.07M |
| 4D Molecular Therapeutics | 507.45M |
| Lyell Immunopharma | 505.53M |
| Rigel Pharmaceuticals | 505.42M |
| YD Bio | 500.89M |
| Entrada Therapeutics | 499.68M |
| Forte Biosciences | 496.23M |